Commentary: The design of prophylactic trials for HIV

Epidemiology

Volumn 14, Issue 1, 2003, Pages 83-84

  Padian, Nancy ^a,b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Dept Obstet Gynecol/Repro Sci ^*  (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; PLACEBO;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; CLINICAL TRIAL; CONDOM; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HETEROSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION CONTROL; NOTE; PRIORITY JOURNAL; PROPHYLAXIS; SEXUALLY TRANSMITTED DISEASE; VIRUS TRANSMISSION;

EID: 3943099366     PISSN: 10443983     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001648-200301000-00019     Document Type: Note

References (1)

1. Stein Z, Myer L, Susser M. The design of prophylactic clinical trials: The case of microbicides for HIV. Epidemiology 2003;14:80-83.